Drug industry embraces new business strategies after tough year

December 9, 2009
A timely year-end analysis of the state of the pharmaceutical industry is scheduled for Chemical & Engineering News, ACS' weekly newsmagazine. Credit: American Chemical Society

As they pop the champagne corks to celebrate New Year's Eve, drug industry executives will likely be glad to put 2009 behind them. That's because pharmaceutical companies who make top-selling drugs for heart disease, asthma, and many other conditions had a tough year in the midst of mounting market pressures and a global recession. A timely year-end analysis of the state of the pharmaceutical industry is scheduled for the current issue of Chemical & Engineering News, ACS' weekly newsmagazine.

C&EN Senior Editor Susan Ainsworth points out in the magazine's cover story that in 2009 drug companies were plagued by patent expirations for superstar drugs, rising competition from generic drugs, and shrinking pipelines for big-ticket products. On top of that, pharmaceutical firms also faced the possibility of U.S. health care reform legislation that could lower future drug pricing and profits, according to the article.

But drug companies are fighting back. They are cutting costs, slashing jobs, and refocusing business units in an attempt to be leaner and more customer-focused, the article notes. It describes how many companies are setting up creative licensing deals, partnerships and acquisitions — including megamergers — to improve operating efficiencies and strengthen new product pipelines. Some companies are also broadening access to their medicines in both established and emerging markets. "The companies that execute well while transforming themselves to compete effectively in this environment will emerge on top," notes the CEO of one major pharmaceutical company.

More information: "Timely Transformation", This story is available at pubs.acs.org/cen/coverstory/87/8749cover.html

Source: American Chemical Society (news : web)

Explore further: Impeding U.S. generic drug use criticized

Related Stories

Study: Pet care industry is booming

June 26, 2007

The American Chemical Society said U.S. pet owners spent $18.5 million last year on veterinary care, medications and other non-food pet supplies.

Component of asphalt eyed as new fuel source

September 23, 2009

The pavement material that cars drive on may wind up in their fuel tanks as scientists seek ways of transforming asphaltenes -- the main component of asphalt -- into an abundant new source of fuel, according to the cover ...

Recalls, food worries spark booming business in food safety

December 2, 2009

Recalls of ground beef, peanut butter, and other foods have done more than raise public awareness and concern about food safety. They also are quietly fueling a boom in the market for food testing equipment and fostering ...

Recommended for you

A new form of real gold, almost as light as air

November 25, 2015

Researchers at ETH Zurich have created a new type of foam made of real gold. It is the lightest form ever produced of the precious metal: a thousand times lighter than its conventional form and yet it is nearly impossible ...

Atom-sized craters make a catalyst much more active

November 24, 2015

Bombarding and stretching an important industrial catalyst opens up tiny holes on its surface where atoms can attach and react, greatly increasing its activity as a promoter of chemical reactions, according to a study by ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.